Understand the source comparison
Best Peptides to Get Back to Training After Injury Ranked: Recovery Mechanism Comparison
BPC-157 VEGF receptor upregulation, angiogenesis promotion Tendons, ligaments, gastric mucosa Tendon ruptures, ligament sprains, muscle tears 4 hours (requires daily dosing) Moderate. Animal models strong, human trials limited TB-500 Actin upregulation, reduce
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF receptor upregulation, angiogenesis promotion
- Tendons, ligaments, gastric mucosa
- Tendon ruptures, ligament sprains, muscle tears
- 4 hours (requires daily dosing)
- Moderate. Animal models strong, human trials limited
- TB-500
- Actin upregulation, reduced fibrosis
- Muscle, connective tissue
- Muscle strains, soft tissue damage
- 7–10 days
- Moderate. Equine studies robust, human data emerging
- GHK-Cu
- Lysyl oxidase activation, collagen cross-linking
- Dense connective tissue
- Tendinopathy, plantar fasciitis
- 1–2 hours
- Moderate. In vitro and animal models validated
- KPV
- NFκB inhibition, anti-inflammatory
- Systemic (gut-derived)
- Chronic inflammation, overuse injuries
- 30 minutes
- Low. Mechanistic studies exist, clinical trials sparse
- MK-677
- GH/IGF-1 secretion via ghrelin receptors
- Systemic (cartilage emphasis)
- Joint injuries, cartilage damage
- 24 hours
- High. Multiple Phase 2 trials in elderly populations
- CJC-1295/Ipamorelin
- Sustained GH pulse extension + discrete GH release
- Systemic (muscle, bone)
- General recovery, strength restoration
- 6–8 days (CJC) / 2 hours (Ipa)
- Moderate. GH dynamics well-characterized
- Hexarelin
- GH release + cardiac ghrelin receptor activation
- Cardiac tissue, systemic
- Overtraining syndrome, myocarditis
- 70 minutes
- Low-Moderate. Cardioprotective effects documented in animals